InBody Co.Ltd Capital Reinvestment Ratio
InBody Co.Ltd capital reinvestment ratio. InBody Co.Ltd (041830) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩9.04 Billion) in capital expenditures (₩3.64 Billion). Check 041830 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of InBody Co.Ltd (2011–2024)
Capital reinvestment ratio of InBody Co.Ltd from 2011 to 2024. This chart tracks InBody Co.Ltd's Capital Reinvestment Ratio across 14 annual periods. Also explore InBody Co.Ltd (041830) net asset momentum to track the company's year-over-year net asset growth rate.
InBody Co.Ltd Capital Reinvestment Ratio by Year (2011–2024)
InBody Co.Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 041830 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | ₩28.58 Billion | ₩7.55 Billion | ▲ +33.8% |
| 2023 | 0.20x | ₩38.69 Billion | ₩7.64 Billion | ▼ -0.1% |
| 2022 | 0.20x | ₩30.42 Billion | ₩6.02 Billion | ▼ -47.6% |
| 2021 | 0.38x | ₩30.35 Billion | ₩11.45 Billion | ▲ +537.4% |
| 2020 | 0.06x | ₩28.50 Billion | ₩1.69 Billion | ▼ -53.4% |
| 2019 | 0.13x | ₩24.21 Billion | ₩3.08 Billion | ▼ -94.5% |
| 2018 | 2.31x | ₩17.70 Billion | ₩40.86 Billion | ▲ +707.1% |
| 2017 | 0.29x | ₩18.58 Billion | ₩5.31 Billion | ▼ -37.9% |
| 2016 | 0.46x | ₩18.24 Billion | ₩8.41 Billion | ▼ -31.8% |
| 2015 | 0.68x | ₩11.18 Billion | ₩7.55 Billion | ▲ +372.3% |
| 2014 | 0.14x | ₩10.26 Billion | ₩1.47 Billion | ▼ -89.2% |
| 2013 | 1.32x | ₩6.99 Billion | ₩9.26 Billion | ▲ +609.8% |
| 2012 | 0.19x | ₩4.36 Billion | ₩812.05 Million | ▼ -57.4% |
| 2011 | 0.44x | ₩5.50 Billion | ₩2.41 Billion | — |